<--- Back to Details
First PageDocument Content
Peptide hormones / Pharmacology / Drug discovery / Porphyrias / Afamelanotide / Pharmaceutical industry / Erythropoietic protoporphyria / Actinic keratosis / Alpha-Melanocyte-stimulating hormone / Medicine / Health / Pharmaceutical sciences
Date: 2012-04-19 14:38:07
Peptide hormones
Pharmacology
Drug discovery
Porphyrias
Afamelanotide
Pharmaceutical industry
Erythropoietic protoporphyria
Actinic keratosis
Alpha-Melanocyte-stimulating hormone
Medicine
Health
Pharmaceutical sciences

Add to Reading List

Source URL: www.clinuvel.com

Download Document from Source Website

File Size: 98,99 KB

Share Document on Facebook

Similar Documents

Medicine / Health / Clinical medicine / Rare diseases / Porphyrias / Lysosomal storage diseases / RTT / Erythropoietic protoporphyria / Glycogen storage disease type II / Disease

How one patient with a rare disease coped with his genetic disorder

DocID: 1r9mW - View Document

Peptides / Peptide hormones / Afamelanotide / Porphyrias / Erythropoietic protoporphyria / Melanocyte-stimulating hormone / EPP / Carotene / Sunless tanning

Microsoft PowerPoint - OrphanDrugs_Genf2015_Barman_Falchetto [Kompatibilitätsmodus]

DocID: 1ooCQ - View Document

Erythropoietic protoporphyria / Porphyrias / Epp

Review of the Environmental Protection (Kwinana) (Atmospheric Wastes) Policy 1999 An Environmental Protection Policy (EPP) is a mechanism for the protection of any portion of the environment or prevention/control of poll

DocID: 17FN4 - View Document

Erythropoietic protoporphyria / Porphyrias

Position DescriptionComplete for Executive Services Positions ONLY)

DocID: 12Xwl - View Document

Erythropoietic protoporphyria / Porphyrias / Epp

“Enhanced Productivity Programme: [removed]” Booklet Report on EPP savings -- Information Technology Services Department Total value of EPP Savings: $6.685m, equivalent to 1% of total Recurrent Baseline Expenditure in

DocID: ZCT9 - View Document